Qiaoli LUO, Yisong WANG, Yuguang GUAN, et al. Analysis of transcriptomic characteristics of brain tissue in patients with Rasmussen encephalitis[J]. Journal of Third Military Medical University, 2020, 42(14): 1407-1413.
DOI:
Qiaoli LUO, Yisong WANG, Yuguang GUAN, et al. Analysis of transcriptomic characteristics of brain tissue in patients with Rasmussen encephalitis[J]. Journal of Third Military Medical University, 2020, 42(14): 1407-1413. DOI: 10.16016/j.1000-5404.202002076.
Analysis of transcriptomic characteristics of brain tissue in patients with Rasmussen encephalitis
To investigate the transcriptomic characteristics of the brain tissue in patients with Rasmussen encephalitis (RE).
Methods
2
RNA-seq technique was used to detect the gene expression profiles in the brain tissues from 4 patients with RE and 4 with temporal lobe epilepsy (TLE) admitted to Sanbo Brain Hospital
Capital Medical University between April
2008 and December
2013.
Results
2
Cluster analysis showed significant differences in the differentially expressed genes (DEGs) in the brain tissue between the patients with RE and those with TLE. We identified a total of 1 285 DEGs
of which 782 (60.9%) were down-regulated and 503 (39.1%) were up-regulated in RE. The up-regulated DEGs were mainly enriched in the pathways associated with neuronal signal transduction
possibly in relation with frequent seizures in patients with RE; the down-regulated DEGs were mainly enriched in the pathways associated with cytoskeleton
cell cycle and chemotaxis
which may be related to neuronal loss and regeneration and immune responses to infection by some pathogens in the brain tissue of patients with RE. TAS2R40
HTR4 and NAP1L2 were identified as the key up-regulated DEGs
and CXXC1
SEPTIN8 and CCR7 as the key down-regulated DEGs.
Conclusion
2
The brain tissue of patients with RE shows characteristic transcriptomic changes
and the DEGs are mainly enriched in neuronal signal transduction
cell cycle and chemotaxis-related pathways.
关键词
Keywords
references
RASMUSSEN T, OLSZEWSKI J, LLOYDSMITH D. Focal seizures due to chronic localized encephalitis[J]. Neurology, 1958, 8(6): 435-445. DOI: 10.1212/wnl.8.6.435.
BIEN C G, GRANATA T, ANTOZZI C, et al . Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement[J ] . Brain, 2005, 128(Pt 3): 454-471. DOI: 10.1093/brain/awh415.
VILLANI F, PINCHERLE A, ANTOZZI C, et al . Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases[J ] .Epilepsia, 2006, 47(Suppl 5): 41-46. DOI: 10.1111/j.1528-1167.2006.00876.x.
WANG Q, ZHU Z, WANG G, et al . Functional hemispherectomy for adult Rasmussen encephalitis: a case report and literature review[J ] . Turk Neurosurg, 2019, 29 (6): 945-949. DOI: 10.5137/1019-5149.jtn.21188-17.1.
VARADKAR S, BIEN C G, KRUSE C A, et al . Rasmussen's encephalitis: clinical features, pathobiology, andtreatment advances[J ] . Lancet Neurol, 2014, 13(2): 195-205. DOI: 10.1016/S1474-4422(13)70260-6.
CEPEDA C, CHANG J W, OWENS G C, et al . In Rasmussen encephalitis, hemichannels associated with microglial activation are linked to cortical pyramidal neuron coupling: a possible mechanism for cellular hyperexcitability[J ] . CNSNeurosci Ther, 2015, 21(2): 152-163. DOI: 10.1111/cns.12352.
GÜNDÜZ A, K 1 Z 1 LTAN M E, COŞKUN T, et al . Electrophysiological findings in Rasmussen's syndrome[J ] . Epileptic Disord, 2016, 18(1): 73-76. DOI: 10.1684/epd.2016.0804..
ROGERS S W, ANDREWS P I, GAHRING L C, et al . Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis[J ] . Science, 1994, 265(5172): 648-651. DOI: 10.1126/science.8036512.
GURCHARRAN K, KARKARE S. Anti-N-methyl-D-aspartate receptor encephalitis and Rasmussen-like syndrome: an association?[J]. Pediatr Neurol, 2017, 66: 104-107. DOI: 10.1016/j.pediatrneurol.2016.10.001.
DI LIBERTO G, PANTELYUSHIN S, KREUTZFELDT M, et al . Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping[J ] . Cell, 2018, 175(2): 458-471.e19. DOI: 10.1016/j.cell.2018.07.049.
CONTE C, EBELING M, MARCUZ A, et al . Identification and characterization of human taste receptor genes belonging to the TAS2R family[J ] . Cytogenet Genome Res, 2002, 98(1): 45-53. DOI: 10.1159/000068546.
PAUWELYN V, CEELEN W, LEFEBVRE R A. Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle[J]. Neurogastroenterol Motil, 2018, 30(2). DOI: 10.1111/nmo.13162.
ROUGEULLE C, AVNER P. Cloning and characterization of a murine brain specific gene Bpx and its human homologue lying within the Xic candidate region[J]. Hum Mol Genet, 1996, 5(1): 41-49. DOI: 10.1093/hmg/5.1.41.
ROGNER U C, SPYROPOULOS D D, LE NOVÈRE N, et al . Control of neurulation by the nucleosome assembly protein-1-like 2[J ] . Nat Genet, 2000, 25(4): 431-435. DOI: 10.1038/78124.
ATTIA M, FÖRSTER A, RACHEZ C, et al . Interaction between nucleosome assembly protein 1-like family members[J ] . J Mol Biol, 2011, 407(5): 647-660. DOI: 10.1016/j.jmb.2011.02.016.
CARLONE D L, SKALNIK D G. CpG binding protein is crucial for early embryonic development[J]. Mol Cell Biol, 2001, 21(22): 7601-7606. DOI: 10.1128/mcb.21.22.7601-7606.2001.
CAO W Q, GUO J, WEN X F, et al . CXXC finger protein 1 is critical for T-cell intrathymic development through regulating H3K4 trimethylation[J ] . Nat Commun, 2016, 7: 11687. DOI: 10.1038/ncomms11687.
LIN F, MENG X, GUO Y, et al . Epigenetic initiation of the T H 17 differentiation program is promoted by CXXC finger protein 1[J ] . Sci Adv, 2019, 5(10): eaax1608. DOI: 10.1126/sciadv.aax1608..
HALL P A, JUNG K, HILLAN K J, et al . Expression profiling the human septin gene family[J ] . J Pathol, 2005, 206(3): 269-278. DOI: 10.1002/path.1789.
BIRKENBACH M, JOSEFSEN K, YALAMANCHILI R, et al . Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors[J ] . J Virol, 1993, 67(4): 2209-2220.
MOUTAFTSI M, BRENNAN P, SPECTOR S A, et al . Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalo- virus-infected dendritic cells[J ] . J Virol, 2004, 78(6): 3046-3054. DOI: 10.1128/jvi.78.6.3046-3054.2004.
ZHANG Y, WANG Y S, CHEN S C, et al . Expression of human cytomegalovirus components in the brain tissues of patients with Rasmussen's encephalitis[J ] . Virol Sin, 2017, 32(2): 115-121. DOI: 10.1007/s12250-016-3917-z.
WANG X, WANG Y S, LIU D, et al . Elevated expression of EBV and TLRs in the brain is associated with Rasmussen's encephalitis[J ] . Virol Sin, 2017, 32(5): 423-430. DOI: 10.1007/s12250-017-4058-8.
LIU D, WANG X, WANG Y S, et al . Detection of EBV and HHV6 in the brain tissue of patients with Rasmussen's encephalitis[J ] . Virol Sin, 2018, 33(5): 402-409. DOI: 10.1007/s12250-018-0063-9.
LAGARDE S, VILLENEUVE N, TRÈBUCHON A, et al . Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: an open pilot study[J ] . Epilepsia, 2016, 57(6): 956-966. DOI: 10.1111/epi.13387.
PAPETTI L, NICITA F, GRAN ATA T, et al . Early add-on immunoglobulin administration in Rasmussen encephalitis: the hypothesis of neuroimmunomodulation[J ] . Med Hypotheses, 2011, 77(5): 917-920. DOI: 10.1016/j.mehy.2011.08.011.